Literature DB >> 17376937

MMR: marginalised, misrepresented and rejected? Autism: a focus group study.

Shona Hilton1, Kate Hunt, Mark Petticrew.   

Abstract

OBJECTIVE: To explore how the measles, mumps, and rubella (MMR) vaccine controversy impacted on the lives of parents caring for children with autism.
DESIGN: Qualitative focus group study.
SETTING: United Kingdom. PATIENTS: A purposively selected sample of 38 parents took part in 10 focus group discussions between March 2003 and May 2005.
RESULTS: Many parents felt that the MMR vaccine could be too potent for children who are susceptible to developing autism. Of the parents whose children received the MMR vaccine, many felt guilty that they may have caused or contributed to their child's autism. Some parents felt frustrated by health professionals' lack of understanding of the negative impact the MMR controversy has had on them. Some parents were anxious about subsequent MMR decision-making for their children.
CONCLUSIONS: The controversy has had a negative impact on some parents of children with autism. This has implications for health professionals, who need to be particularly aware of the issues these parents face in future MMR decision-making for their affected child and younger siblings. It is anticipated that these findings will raise awareness among health professionals of the difficulties faced by such parents. More generally, there is a need to promote a greater awareness of the important role health visitors can play in parental decision-making and for research examining whether health professionals feel they receive sufficient training in communication skills. It is also essential that the latest scientific research findings are disseminated quickly to these parents and to those health professionals advising parents on matters of vaccine safety.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376937      PMCID: PMC2083659          DOI: 10.1136/adc.2006.109686

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  29 in total

Review 1.  Qualitative research in health care. Analysing qualitative data.

Authors:  C Pope; S Ziebland; N Mays
Journal:  BMJ       Date:  2000-01-08

2.  No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.

Authors:  H Peltola; A Patja; P Leinikki; M Valle; I Davidkin; M Paunio
Journal:  Lancet       Date:  1998-05-02       Impact factor: 79.321

3.  Autism, inflammatory bowel disease, and MMR vaccine.

Authors:  C Payne; B Mason
Journal:  Lancet       Date:  1998-03-21       Impact factor: 79.321

4.  MMR vaccination and autism 1998.

Authors:  A Nicoll; D Elliman; E Ross
Journal:  BMJ       Date:  1998-03-07

5.  Absence of measles-virus genome in inflammatory bowel disease.

Authors:  M A Afzal; P D Minor; J Begley; M L Bentley; E Armitage; S Ghosh; A Ferguson
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

6.  Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up.

Authors:  A Patja; I Davidkin; T Kurki; M J Kallio; M Valle; H Peltola
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

7.  UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe.

Authors:  B Hanratty; T Holt; E Duffell; W Patterson; M Ramsay; J M White; L Jin; P Litton
Journal:  Epidemiol Infect       Date:  2000-10       Impact factor: 2.451

8.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

Authors:  B Taylor; E Miller; C P Farrington; M C Petropoulos; I Favot-Mayaud; J Li; P A Waight
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

9.  Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism.

Authors:  H Kawashima; T Mori; Y Kashiwagi; K Takekuma; A Hoshika; A Wakefield
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

10.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

View more
  6 in total

Review 1.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 2.  Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.

Authors:  Heather Mr Ames; Claire Glenton; Simon Lewin
Journal:  Cochrane Database Syst Rev       Date:  2017-02-07

Review 3.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

Review 4.  Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.

Authors:  Sara Cooper; Bey-Marrié Schmidt; Evanson Z Sambala; Alison Swartz; Christopher J Colvin; Natalie Leon; Charles S Wiysonge
Journal:  Cochrane Database Syst Rev       Date:  2021-10-27

5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

6.  Vaccines and autism: a preliminary qualitative study on the beliefs of concerned mothers in Italy.

Authors:  Monica Pivetti; Giannino Melotti; Claudia Mancini
Journal:  Int J Qual Stud Health Well-being       Date:  2020-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.